Aurobindo Pharma reported INR80.73B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Cipla INR 6.14B 1.76B Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Dr.Reddys Laboratories INR 71.95B 5.39B Jun/2026
Hindustan Unilever INR 14.78B 1.7B Mar/2026
Sun Pharmaceuticals INR 46.27B 22.65B Mar/2026
UPL INR 235.76B 15.23B Mar/2026